1.60
Health Catalyst Inc stock is traded at $1.60, with a volume of 320.69K.
It is up +1.91% in the last 24 hours and up +36.75% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.57
Open:
$1.57
24h Volume:
320.69K
Relative Volume:
0.38
Market Cap:
$118.23M
Revenue:
$311.14M
Net Income/Loss:
$-177.97M
P/E Ratio:
-0.6317
EPS:
-2.5329
Net Cash Flow:
$-20.82M
1W Performance:
+19.40%
1M Performance:
+36.75%
6M Performance:
-47.54%
1Y Performance:
-60.69%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
1.60 | 116.01M | 311.14M | -177.97M | -20.82M | -2.5329 |
|
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
3 Reasons to Avoid HCAT and 1 Stock to Buy Instead - Yahoo Finance
[Form 4] Health Catalyst, Inc. Insider Trading Activity - Stock Titan
Health Catalyst (NASDAQ: HCAT) director Nelson submits initial Form 3 - Stock Titan
MSN Money - MSN
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
8x8, Veeva Systems, and Health Catalyst Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Officer Albert Benjamin - Moomoo
Health Catalyst (NASDAQ: HCAT) restricted stock sale notice by affiliate - Stock Titan
Health Catalyst (HCAT) CEO receives PRSUs, sells shares to cover taxes - Stock Titan
Health Catalyst 2025 Executive Compensation: Pay-for-Performance Philosophy, Metrics, and Practices Explained - Minichart
Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026 - The Manila Times
Health Catalyst to post quarterly results after the close on May 11 - Stock Titan
Health Catalyst | 10-K/A: Annual report (Amendment) - Moomoo
Executive pay and leadership shifts at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Health Catalyst Adds Steve Nelson to Board of Directors - TipRanks
Health Catalyst | 8-K: Current report - Moomoo
Health Catalyst adds Aetna executive to board of directors - Investing.com
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors - The Manila Times
Health Catalyst adds Aetna executive to board of directors By Investing.com - Investing.com UK
Health Catalyst Appoints Steve Nelson to Board of Directors to Strengthen Leadership in Healthcare Intelligence - Quiver Quantitative
Aetna president joins Health Catalyst board after CEO, chair changes - Stock Titan
Aetna president Steve Nelson joins Health Catalyst (HCAT) board amid leadership refresh - Stock Titan
Winners And Losers Of Q4: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart.com
Health Catalyst (HCAT) to Release Quarterly Earnings on Wednesday - MarketBeat
Health Catalyst (HCAT) price target decreased by 45.97% to 2.14 - MSN
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
HCAT Announces Workforce Reduction as Part of Strategic Overhaul - GuruFocus
Health Catalyst (HCAT) Announces Changes to Executive Leadership - GuruFocus
Health Catalyst Inc board authorizes workforce reduction on April 24, 2026 under Project Nexus - marketscreener.com
According to the latest filing disclosed by the U.S. Securities and Exchange Commission, Health Catalyst, Inc. announced a change in position for its Chief People Officer, Linda Llewelyn. - Bitget
Health Catalyst Announces Restructuring and Workforce Reduction Plan - TipRanks
Project Nexus: Health Catalyst (NASDAQ: HCAT) trims workforce and reshapes roles - Stock Titan
Ambulatory Control: The Growth Engine Under Pressure - Modern Healthcare
Q4 2024 Health Catalyst Inc Earnings Call Transcript - GuruFocus
Health Catalyst (HCAT) may find a bottom soon, here's why you should buy the stock now - MSN
Health Catalyst (HCAT) Stock Pending Order (Volatility Increases) 2026-04-22Open Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
HCAT Financials: Income Statement, Balance Sheet & Cash Flow | Health Catalyst - Stock Titan
HCAT Forecast, Price Target & Analyst Ratings | HEALTH CATALYST INC (NASDAQ:HCAT) - ChartMill
Citigroup Maintains Health Catalyst (HCAT) Neutral Recommendation - MSN
Health Catalyst (HCAT) Stock: Is It Trading at Premium (Risk Aversion) 2026-04-20Momentum Picks - Cổng thông tin điện tử Tỉnh Sơn La
How does market volatility impact Health Catalyst (HCAT) stock (Gains) 2026-04-18High Beta Stocks - Xã Thanh Hà
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 59.7% Potential Upside Amidst Challenging Performance Metrics - DirectorsTalk Interviews
Health Catalyst and ZoomInfo Stocks Trade Up, What You Need To Know - Yahoo Finance
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Health Catalyst (HCAT) Stock: Summer Outlook (Rockets) 2026-04-15Crowd Trend Signals - UBND thành phố Hải Phòng
Global Patient Engagement Solutions Market to Grow by - GlobeNewswire
Global Patient Engagement Solutions Market to Grow by $21.76 Billion Through 2030McKesson, Veradigm, Oracle, Athenahealth, and Health Catalyst Dominate - Yahoo Finance
Health Catalyst, Commerce, DocuSign, Unity, and Workiva Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (HCAT) cut to equal weight at Wells Fargo on prolonged revenue, margin pressure - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):